A Product Advisory is a voluntary letter issued to inform physicians of an anomalous device behavior identified by Boston Scientific's Quality System.

A Product Advisory is issued when there is a material elevation in risk to patient safety with potential for compromised lifesaving therapy, or when Boston Scientific can provide meaningful guidance to improve patient outcomes or device performance.

Neuromodulation - Product Advisories

Superion Indirect Decompression System (IDS) - June 2025 Removal

U.S. Customer Letter

----------------------------------------------------------------------------------------------------

Vercise Genus Deep Brain Stimulation (DBS) - August 2024 Subpec Advisory

U.S. Customer Advisory Letter

U.S. Customer Letter Attachment

U.S. Patient Advisory Letter

----------------------------------------------------------------------------------------------------

WaveWriter Alpha Spinal Cord Stimulation (SCS) - July 2024 Product Advisory 

U.S. Customer Advisory Letter

U.S. Patient Advisory Letter

----------------------------------------------------------------------------------------------------

Vercise Genus Deep Brain Stimulation (DBS) - July 2024 Product Advisory Update 

U.S. Customer Advisory Letter

U.S. Patient Advisory Letter

----------------------------------------------------------------------------------------------------

Vercise Genus Deep Brain Stimulation (DBS) - April 2024 Product Advisory 

U.S. Customer Advisory Letter

----------------------------------------------------------------------------------------------------

Superion Instruments - May 2023 Product Advisory

Advisory Customer Letter - English

Advisory Patient Letter - English

Cardiac Rhythm Management Product Advisories

High Internal Battery Impedance in a Subset of ACCOLADE Pacemakers and CRT-Ps - September 2025 Product Advisory Update

U.S. Customer Advisory Letter

U.S. Patient Advisory Letter

French Customer Advisory Letter

----------------------------------------------------------------------------------------------------

RELIANCE ePTFE Potential Calcification/Gradually Rising LVSI - July 2025 Advisory

U.S. Customer Advisory Letter

U.S. Patient Advisory Letter

----------------------------------------------------------------------------------------------------

High Internal Battery Impedance in a Subset of ACCOLADE Pacemakers and CRT-Ps - December 2024 Product Advisory

U.S. Customer Advisory Letter

U.S. Patient Advisory Letter

Patient Advisory Letter - French

----------------------------------------------------------------------------------------------------

INGENIO High Battery Impedance - November 2023 Product Advisory Update

U.S. Customer Advisory Letter

U.S. Patient Advisory Letter

----------------------------------------------------------------------------------------------------

Model 3120 ZOOM Programmer with Model 2892 Software - November 2023 Product Advisory

U.S. Customer Advisory Letter

----------------------------------------------------------------------------------------------------

EMBLEM S-ICD Temporary Sensing Pause - July 2023 Product Advisory

U.S. Customer Advisory Letter

U.S. Patient Advisory Letter

----------------------------------------------------------------------------------------------------

Inability to Interrogate 2868 SW on Model 3120 Programmer - July 2022 Advisory

International Field Safety Notice - EU English

International Customer Correction Letter - EU English

U.S. Customer Advisory Letter - English

----------------------------------------------------------------------------------------------------

EMBLEM Enhanced Premature Battery Depletions - February 2022 Advisory Update

U.S. Customer Advisory Update Letter - English

U.S. Patient Advisory Update Letter - English

----------------------------------------------------------------------------------------------------